Also, inhibition of mTORC1 by genetic and pharmacological tools restores insulin secretion in human T2D islets as well as in islets of diabetic mice41, 48 and corrects metabolic derangement in metabolically stressed β-cells49. The gene discussed is INS; the disease is type 2 diabetes mellitus.